[PDF] Top 20 FORMULATION AND IN-VITRO EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF LEVOFLOXACIN

... Drug Release [11&12] : To study the mechanism of drug release from the matrix tablets, the drug release data were fitted to various kinetic models like zero order, first order, ... See full document

... extended release tablets: Influence of tablet formulation, hardness and storage on in vitro release ...extended release tablet, which can release the drug for six hours in ... See full document

... Levofloxacin matrix floating tablets were prepared by direct compression method employing sodium bicarbonate as gas- generating agent. HPMC and Carbopol were used as rate controlling polymers. The ... See full document

... еffеctivе and non-toxic fir an еxtеndеd реriod of timе. Thе dеsign of рroреr dosagе form is an imрortant еlеmеnt to accomрlish this goal. Sustainеd rеlеasе, sustainеd action, рrolongеd action, controllеd rеlеasе, ... See full document

... compressed Tablets were tested for weight variation, thickness, hardness, friability, and uniformity of dosage ...Drug release profiles of formulations F1, F2, F3, F4, and F5 were conducted for about ... See full document

... formulate Sustained Release matrix tablets of Glimepiride in a matrix design utilizing different percentages of hydrophilic ...controlled release polymers such as HPMC K4M, HPMC ... See full document

... develop matrix tablets of levofloxacin for sustained ...various formulation factors such as polymer proportion and effect of filler type on the in vitro release of the ... See full document

... The release rate of gliclazide from matrix tablets was determined using United States Pharmacopoeia dissolution testing apparatus I (Basket method; Veego Scientific VDA-8DR, Mumbai, ...each ... See full document

... evaluate sustained release matrix tablets of levofloxacin, to reduce the side effects and improved patient ...In Levofloxacin the active component is race mate ofloxacin, is used ... See full document

... the sustained release (SR) forms extremely advantageous. Sustained release tablets results in increased ...sustain release matrix drug delivery system (SR) containing ... See full document

... improved sustained released ambroxol hydrochloride dosage form that slowly release its active ingredients, such that it will maintain therapeutically effective levels of the active drug in the blood stream ... See full document

... twice-daily sustained-release matrix tablets of Nitazoxanide using different concentrations of hydrophilic ...Nitazoxanide sustained-release tablets by using HPMC ... See full document

... Oral sustained release dosage forms have been developed for the past three decades due to their considerable therapeutic ...of matrix tablet as sustained release has given a new ... See full document

... apparatus, with 900 ml of dissolution medium maintained at 37±1°C for 15 h, at 50 rpm. 0.1 N HCl (pH 1.2) was used as a dissolution medium for the first 2 h, followed by pH 6.8 phosphate buffers for further 10 h. 5ml of ... See full document

... the release exponent indicating the type of drug release ...the release curves where Q ...the release mechanism can be Fickian. If n approaches to 1, the release mechanism can be zero ... See full document

... The method of development of Nifedipine matrix tablets is Direct Compression method.Direct compression is a popular choice. The prime advantage of direct compression over wet granulation is economic since ... See full document

... formulate sustained release tablets of Carvedilol by solid dispersion technique for improving solubility of Carvedilol using Poloxamer 407 and PVP ...carvedilol tablets were prepared by direct ... See full document

... mg tablets) of Indapamide to male subjects produced peak concentrations of approximately 115 ng/mL of the drug in blood within two ...mg tablets) of Indapamide to healthy male subjects produced peak ... See full document

... The tablets were evaluated for physical parameters, in vitro release study and stability ...In-vitro release indicated that the formulation F2 had better dissolution profile ... See full document

... Lornoxicam release from formulation F7 was slow and spread over 16 ...Drug release from formulation F8 was again very slow and was only about 37% in 24 ...the formulation F8 is also ... See full document